 Cohort A 10 subjects Subjects with NF1 and inoperable PNs as per Phase I and Cohort B 10 subjects Subjects with NF-1 related progressive optic pathway glioma are eligible if the subject has evidence of either clinical e.g. worsening visual function as per REiNS or MRI based significant radiological progression and has had at least two lines of standard therapy. 